CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common stock:	Additional paid-in-capital:	Treasury stock at cost:	Retained earnings:	Accumulated other comprehensive income:
Balance, beginning of year at Dec. 31, 2019		$ 2	$ 16,126	$ (31,396)	$ 17,754	$ 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		0
Common stock repurchased		0	0	(5,119)
Common stock and stock-based awards issued			89
Tax withholdings related to net share settlements of restricted stock awards and units			(175)
Stock-based compensation			463
Other			(6)
Net income (loss)	$ 5,667				5,667
Dividends and dividend equivalents declared					(460)
Change in unrealized gains (losses) on investments	0					0
Change in unrealized gains (losses) on derivative instruments						(76)
Foreign currency translation adjustment						291
Tax benefit (provision) on above items						17
Balance, end of year at Dec. 31, 2020	$ 3,561	$ 2	16,497	(36,515)	22,961	616
Common stock, beginning of year (in shares) at Dec. 31, 2019		796
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)		12
Common stock repurchased (in shares)		(124)
Common stock, end of period (in shares) at Dec. 31, 2020		684
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 0.64
Common stock issued		$ 0
Common stock repurchased		0	(188)	(6,856)
Common stock and stock-based awards issued			93
Tax withholdings related to net share settlements of restricted stock awards and units			(236)
Stock-based compensation			497
Other			(4)
Net income (loss)	$ 13,608				13,608
Dividends and dividend equivalents declared					(479)
Change in unrealized gains (losses) on investments	(12)					(12)
Change in unrealized gains (losses) on derivative instruments						150
Foreign currency translation adjustment						(326)
Tax benefit (provision) on above items						(30)
Balance, end of year at Dec. 31, 2021	$ 9,778	$ 2	16,659	(43,371)	36,090	398
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)		10
Common stock repurchased (in shares)		(100)
Common stock, end of period (in shares) at Dec. 31, 2021	594	594
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 0.72
Common stock issued		$ 0
Common stock repurchased	$ (3,143)	0	188	(3,331)
Common stock and stock-based awards issued			87
Tax withholdings related to net share settlements of restricted stock awards and units			(160)
Stock-based compensation			494
Other			11
Net income (loss)	(1,269)				(1,269)
Dividends and dividend equivalents declared					(506)
Change in unrealized gains (losses) on investments	(91)					(91)
Change in unrealized gains (losses) on derivative instruments						49
Foreign currency translation adjustment						(106)
Tax benefit (provision) on above items						9
Balance, end of year at Dec. 31, 2022	$ 5,153	$ 2	$ 17,279	$ (46,702)	$ 34,315	$ 259
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)		10
Common stock repurchased (in shares)	(62)	(65)
Common stock, end of period (in shares) at Dec. 31, 2022	539	539
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 0.88